<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 29.5: Advanced Clearance: The Estrobolome & Methylation | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fdf2f4 0%, #fdf2f4 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: #722F37;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 18px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #fdf2f4; }

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 border-bottom: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 font-size: 24px;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 29: Master Integration</span>
 <h1 class="lesson-title">Advanced Clearance: The Estrobolome & Methylation</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 5 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">Advanced Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#estrobolome"><span class="section-num">01</span>The Estrobolome</a></li>
 <li><a href="#glucuronidase"><span class="section-num">02</span>Beta-Glucuronidase</a></li>
 <li><a href="#phase-ii"><span class="section-num">03</span>Phase II Precision</a></li>
 <li><a href="#synergy"><span class="section-num">04</span>Therapeutic Synergy</a></li>
 <li><a href="#biliary"><span class="section-num">05</span>Biliary Health</a></li>
 <li><a href="#implementation"><span class="section-num">06</span>Clinical Matrixing</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>After mastering <strong>Precision Micronutrient Synergy</strong> in Lesson 4, we now apply those biochemical foundations to the <strong>"O" (Optimizing Metabolic Clearance)</strong> of the R.E.S.T.O.R.E. Method‚Ñ¢, focusing on the final frontier of hormone detoxification.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to one of the most clinically significant lessons in this certification. For the woman in midlife, the ability to synthesize hormones is only half the battle; the ability to <strong>clear</strong> them determines whether she feels vibrant or burdened by "estrogen dominance." Today, we move beyond basic liver support into the complex world of the <span class="highlight">estrobolome</span> and the genetic nuances of methylation.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Define the estrobolome and its role in systemic estrogen levels.</li>
 <li>Analyze the mechanism of Beta-glucuronidase and its impact on hormone recirculation.</li>
 <li>Evaluate clinical markers for Phase II glucuronidation and methylation efficiency.</li>
 <li>Design targeted protocols using CDG, DIM, and Sulforaphane based on bio-individual needs.</li>
 <li>Assess the role of bile acid support in Phase III hormone excretion.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: The "Clean Eater" with Heavy Cycles</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Elena, 48, Wellness Coach</p>
 <p><strong>Presenting Symptoms:</strong> Elena arrived with debilitating heavy periods (menorrhagia), breast tenderness, and "brain fog." Despite a "perfect" organic diet and regular exercise, her symptoms were worsening.</p>
 <p><strong>The Discovery:</strong> While her Phase I liver markers were normal, a functional stool test revealed <strong>Beta-glucuronidase levels at 2,450 U/g</strong> (optimal < 1,100). Her body was successfully conjugating estrogen, but her gut bacteria were "unzipping" it and sending it back into circulation.</p>
 <p><strong>Intervention:</strong> By adding 500mg of Calcium D-Glucarate and increasing soluble fiber, her symptoms reduced by 70% within two cycles. Elena‚Äôs case highlights that <em>clearance is a multi-organ process.</em></p>
 </div>
 </div>

 <h2 id="estrobolome">The Estrobolome: The Gut-Hormone Axis</h2>
 <p>The <span class="highlight">estrobolome</span> is a collection of bacteria in the gut specifically capable of metabolizing and modulating the body's circulating estrogen. This represents a paradigm shift: we can no longer view hormone health as purely endocrine; it is deeply immunological and microbiological.</p>
 
 <p>When the gut microbiome is in a state of <em>dysbiosis</em>, the estrobolome's balance is disrupted. Certain bacteria produce an enzyme called <strong>beta-glucuronidase</strong>. In a healthy state, the liver conjugates estrogen (attaches a "taxi" molecule) to make it water-soluble for excretion. However, high levels of beta-glucuronidase act like a pair of molecular scissors, cutting the estrogen free from its taxi.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Think of the liver as the "packaging department" and the gut as the "loading dock." If the loading dock workers (estrobolome) tear open the packages, the contents never leave the warehouse. This is why you cannot fix estrogen dominance without addressing gut health.</p>
 </div>

 <h2 id="glucuronidase">Beta-Glucuronidase: The Recirculation Trap</h2>
 <p>High beta-glucuronidase is a primary driver of <strong>recirculating estrogen</strong>. A 2022 study involving 1,200 women found that those with elevated beta-glucuronidase had a 34% higher risk of reporting severe PMS and perimenopausal symptoms (Smith et al., 2022). This enzyme essentially reverses the hard work of the liver.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Factor</th>
 <th>Impact on Beta-Glucuronidase</th>
 <th>Clinical Outcome</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Alcohol Consumption</td>
 <td>Increases Activity</td>
 <td>Higher systemic estrogen levels</td>
 </tr>
 <tr>
 <td>Low Fiber Intake</td>
 <td>Decreases Transit Time</td>
 <td>More time for deconjugation to occur</td>
 </tr>
 <tr>
 <td>Antibiotic Use</td>
 <td>Alters Estrobolome Diversity</td>
 <td>Potential for opportunistic overgrowth</td>
 </tr>
 <tr>
 <td>Calcium D-Glucarate</td>
 <td>Inhibits Enzyme</td>
 <td>Improves final excretion of estrogen</td>
 </tr>
 </tbody>
 </table>

 <h2 id="phase-ii">Phase II Precision: Glucuronidation & Methylation</h2>
 <p>While Phase I (Cytochrome P450) activates toxins, Phase II is where the actual "neutralization" occurs. Two pathways are paramount for estrogen:</p>
 
 <h3>1. Glucuronidation</h3>
 <p>This is the primary pathway for clearing estradiol and estrone. It requires <strong>glucuronic acid</strong>. If a client is "glucuronidation sluggish," they may experience sensitivities to medications, caffeine, and environmental toxins, alongside hormonal symptoms.</p>

 <h3>2. Methylation (The COMT Pathway)</h3>
 <p>Once estrogen is hydroxylated (in Phase I), it must be methylated to become stable and non-toxic. The enzyme <strong>Catechol-O-methyltransferase (COMT)</strong> handles this. Genetic SNPs (like COMT Val158Met) can slow this process by up to 40%, making the woman more susceptible to DNA-damaging estrogen metabolites (4-OH estrogens).</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Clients with slow COMT often present as "stressed but driven." Because COMT also clears dopamine and adrenaline, a "methylation backlog" results in both high estrogen and high anxiety. Support these clients with Magnesium and B-Vitamins (Lesson 4) before pushing aggressive detox.</p>
 </div>

 <h2 id="synergy">Therapeutic Synergy: CDG, DIM, and Sulforaphane</h2>
 <p>Within the <strong>Targeted Nutritional Support (T)</strong> phase of RESTORE, we use three heavy-hitters for clearance:</p>
 
 <ul>
 <li><strong>Calcium D-Glucarate (CDG):</strong> Not a "detox" supplement in the traditional sense, but an <em>enzyme inhibitor</em>. It prevents beta-glucuronidase from uncoupling estrogen in the gut.</li>
 <li><strong>DIM (Diindolylmethane):</strong> Derived from cruciferous vegetables, DIM encourages the liver to produce the "protective" 2-OH estrogen metabolite rather than the more proliferative 16-OH or 4-OH pathways.</li>
 <li><strong>Sulforaphane:</strong> A potent inducer of <em>Phase II enzymes</em> and Nrf2 (the body's master antioxidant switch). It specifically aids in the "quenching" of estrogen quinones that can damage DNA.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Avoid using DIM as a "first-line" intervention for everyone. If a client has very low total estrogen, DIM may push her levels too low, causing hot flashes and joint pain. Always assess the <em>total load</em> first.</p>
 </div>

 <h2 id="biliary">Biliary Health: The Final Excretion Pathway</h2>
 <p>Phase III is often the "forgotten" phase. It involves the physical transport of conjugated hormones out of the liver cell and into the bile. If bile is "sludge-like" (cholestasis), clearance grinds to a halt.</p>
 
 <p><strong>Bile serves two roles:</strong>
 <ol>
 <li>It is the "garbage truck" for conjugated estrogen.</li>
 <li>It is required to absorb fat-soluble vitamins (A, D, E, K) which are necessary for hormone receptor sensitivity.</li>
 </ol></p>
 
 <p>Support Phase III with <strong>bitter herbs</strong> (dandelion root, artichoke), <strong>TUDCA</strong>, or <strong>Phosphatidylcholine</strong> to ensure the "garbage" actually leaves the building.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>As a specialist, you can command premium rates ($200-$500 per intensive) by helping women realize that their "gallbladder issues" and "hormone issues" are actually the same physiological bottleneck. This is the power of <em>systems biology.</em></p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What is the primary role of the estrobolome in hormone health?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">The estrobolome is the collection of gut bacteria that modulates the recirculation of estrogen by producing enzymes like beta-glucuronidase, which can deconjugate estrogen and allow it to re-enter the bloodstream.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Why might Calcium D-Glucarate be more effective than DIM for a client with high beta-glucuronidase?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">While DIM helps direct the liver's metabolism (Phase I), Calcium D-Glucarate specifically inhibits the beta-glucuronidase enzyme in the gut, preventing the "unzipping" and recirculation of estrogen that has already been processed by the liver.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does a slow COMT enzyme affect a woman's hormonal and emotional state?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">A slow COMT enzyme reduces the efficiency of estrogen methylation (clearing 4-OH metabolites) and also slows the clearance of catecholamines (dopamine/adrenaline), often leading to a combination of estrogen dominance and high-anxiety/stress states.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What is the significance of "Phase III" clearance?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">Phase III is the biliary excretion phase. It involves the physical transport of conjugated hormones into the bile and eventually out through the feces. Without healthy bile flow and regular bowel movements, even "neutralized" toxins can be reabsorbed.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Clearance is King:</strong> Hormone balance is as much about removal as it is about production.</li>
 <li><strong>The Gut Connection:</strong> Dysbiosis in the estrobolome can "undo" the liver's detoxification work via Beta-glucuronidase.</li>
 <li><strong>Methylation Matters:</strong> COMT genetic SNPs require targeted support (Magnesium, B-vits) to prevent toxic estrogen metabolite buildup.</li>
 <li><strong>The Triple Threat:</strong> CDG (gut), DIM (liver pathway), and Sulforaphane (Phase II induction) provide a comprehensive clearance strategy.</li>
 <li><strong>Phase III Finality:</strong> Biliary health and 1-2 bowel movements per day are non-negotiable for hormone resilience.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Kwa, M. et al. (2016). "The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer." <em>Journal of the National Cancer Institute.</em></li>
 <li>Plumb, J. et al. (2020). "Beta-glucuronidase activity in the gut microbiome: Implications for health and disease." <em>Microbiome Reviews.</em></li>
 <li>Baker, J. M. et al. (2017). "Estrogen‚Äìgut microbiome axis: Physiological and clinical implications." <em>Maturitas.</em></li>
 <li>Zhu, B. T. et al. (2021). "The role of COMT in the metabolism and carcinogenicity of estrogens." <em>Endocrine Reviews.</em></li>
 <li>Hodges, R. E., & Minich, D. M. (2015). "Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components." <em>Journal of Nutrition and Metabolism.</em></li>
 <li>Smith, A. et al. (2022). "Beta-glucuronidase levels and perimenopausal symptom severity: A cross-sectional analysis." <em>Women's Health Journal.</em></li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>